Skip to content
lifestyle.floredechampagne.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
CG Oncology Inc.
CG Oncology to Present at Upcoming Investor Conferences in September
September 2, 2026
CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 19, 2026
CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology
August 18, 2026
CG Oncology to Present at Upcoming Investor Conferences in June
May 28, 2026
SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
May 19, 2026
CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
May 15, 2026
CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC
May 11, 2026
CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates
May 8, 2026
CG Oncology to Present at Upcoming Investor Conferences in May
May 5, 2026